Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ailon Pharma Oy
OY
Active
Y-tunnus 3157653-9
Tykistökatu 4A-4565, 20520
Turku
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2020
2 employees
www.ailonpharma.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ailon Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
EBITDA
EUR millions
0M
3M
5M
8M
10M
0M
2021
0M
2022
9M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
23
−1
356
658
867
Staff expenses
−12
−23
−47
−122
−168
EBITDA
−5
−74
8 824
65
158
Depreciation & amort.
—
−2
−6
−22
−68
EBIT
−5
−76
8 818
43
91
Net financials
−2
−6
−13
−16
−21
Profit before tax
−8
−82
7 537
27
70
Tax
−0
−0
−0
3
15
Net profit
−8
−82
7 537
23
55
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
145
119
252
322
495
Equity
32
−50
25
49
102
Long-term debt
94
137
144
176
230
Short-term debt
19
32
82
97
162
Total debt
112
169
226
274
393
Financial ratios
5-year trend
EBITDA margin
18.3%
This company
15.8%
Market median
+16% vs market
2021
2025
Equity ratio
20.6%
This company
38.2%
Market median
-46% vs market
2021
2025
Return on equity
54.4%
This company
18.4%
Market median
+196% vs market
2021
2025
Net profit margin
6.4%
This company
8.1%
Market median
-21% vs market
2021
2025
Asset turnover
1.75×
This company
1.12×
Market median
+56% vs market
2021
2025
Debt / equity
3.85×
This company
0.62×
Market median
-521% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-10-01 – 2021-09-30
View
PDF
More on Ailon Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network